semaglutide attorney in louisiana Ozempic Lawyer louisiana semaglutide gi obstruction attorney

Chart B: 5mg vial + 2mL water = 2.5mg/mL (standard) This is the chart from the main titration section above

1,2 The results are consistent with actions taken by the European Medicines Agency (EMA) in June 2025, when the agency classified NAION as a very rare side effect of semaglutide and recommended product labeling updates. Epidemiologic data reviewed by the EMA suggested an approximately twofold increased risk in adults with type 2 diabetes, corresponding to roughly one additional case per 10,000 person-years of treatment. The agency advised that patients with sudden vision loss or rapidly worsening eyesight seek immediate medical attention and discontinue treatment if NAION is confirmed. READ MORE: Blinding Disease-Weight Loss Drug Link: EMA Announces Start of Semaglutide Investigation Study strengths Methodologically, the VA study offers several strengths: The analysis leveraged the largest integrated health care system in the United States, with medication exposure confirmed through pharmacy dispensing records rather than prescription data alone

If side effects appear at a higher dose, return to the previously tolerated dose

Here's what long-haul flying with diabetes actually looks like and how to handle it

Consistency ensures proper absorption and lowers the likelihood of missing a dose

The side effect profile is generally similar, but there are some considerations specific to compounded versions